[1]
2026. Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies. Drug Discovery and Development. 2, 1 (Apr. 2026), 1–16. DOI:https://doi.org/10.5530/ddd.2.1.1.